BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive the group posted full-year 2020 financial results on Wednesday that saw its consolidated revenue rise 31% year-over-year as its cleantech technologies gained commercial traction. Calvert says in terms of debt, in March, BioLargo retired an additional $650,000 in debt. Other than debt owed by its partially owned subsidiary Clyra Medical, only SBA/PPP loans and fixed-price convertible debt now remain on BioLargo's balance sheet.
BioLargo reports 2020 results that sees revenue rise 31% as its cleantech products gain traction
